Annals of Family Medicine
NOVEMBER 20, 2024
The Osteoarthritis Severity Index (OASI) was developed to inform clinical trajectory of knee OA toward TKA and was previously created and validated in a nationally distributed, general population cohort of EHR data. Dataset: VHA-CDW data from 2007-2020.
The Clinical Problem Solvers
MAY 9, 2021
The answer to this question may not be easily answered and may not always be found in the clinical setting. However it is important to remember that this political invention DOES affect biology because of the way that it creates social inequity. Pearls: “Genetics is not the end all be all of understanding disease” – Dorothy E.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PEMBlog
AUGUST 14, 2024
Dexmedetomidine: a review of clinical applications. 2007 Mar;8(2):115-31. What is Dexmedetomidine? Dexmedetomidine, often known by its brand name Precedex, is a fascinating medication. It’s a highly selective central alpha-2 agonist that’s able to induce a state of sedation that closely mimics natural sleep. Plus, it’s versatile!
PEMBlog
JUNE 14, 2023
Children’s Mental Health Emergency Department Visits: 2007-2016. Characteristics, Clinical Care, and Disposition Barriers for Mental Health Patients Boarding in the Emergency Department. It is also the final episode in a 5 episode series focused on agitation in children and adolescents. Pediatrics. 2020 Jun;145(6):e20191536.
FDA Law Blog
MAY 3, 2021
On April 28, FDA issued its first Notice of Noncompliance for failure to submit required clinical trial results information to ClinicalTrials.gov. The ClinicalTrials.gov database is a public database of clinical studies administered by the U.S. Cato & Michelle L. The notice was given to Acceleron Pharma, Inc., 42 U.S.C. §
FDA Law Blog
MAY 3, 2021
Butler — On April 28, FDA issued its first Notice of Noncompliance for failure to submit required clinical trial results information to ClinicalTrials.gov. The ClinicalTrials.gov database is a public database of clinical studies administered by the U.S. Cato & Michelle L. The notice was given to Acceleron Pharma, Inc., 42 U.S.C. §
The Clinical Problem Solvers
FEBRUARY 8, 2023
Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. Dr. Jordan then questions the utility and continued operation of methadone clinics, especially as the United States largely moves on from the COVID-19 pandemic.
Expert insights. Personalized for you.
130 
Let's personalize your content